You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for STRIANT


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for STRIANT

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free T1500_SIGMA ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-14899 ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free T0027 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015894897 ⤷  Get Started Free
AbaChemScene ⤷  Get Started Free CS-1415 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: STRIANT

Last updated: August 1, 2025

Introduction

Striant is a testosterone buccal system prescribed for testosterone replacement therapy in adult males with testosterone deficiency. As a critical component in its formulation, the active pharmaceutical ingredient (API), testosterone, demands strict sourcing standards to ensure product safety, efficacy, and regulatory compliance. This article explores the landscape of bulk API sources dedicated to manufacturing testosterone used specifically in Striant, highlighting key suppliers, industry trends, quality standards, and strategic considerations for pharmaceutical companies.

Overview of Testosterone API in Striant

Testosterone API utilized in Striant is synthesized under stringent regulatory conditions, adhering to Good Manufacturing Practices (GMP), and must meet specifications defined by agencies like the FDA and EMA. The pharmaceutical grade testosterone serves as the core pharmacological agent and is subject to rigorous quality control regarding purity, bioavailability, and stability.

Striant’s proprietary buccal delivery system necessitates high-purity testosterone API with precise particle size and formulation attributes to optimize adhesion and absorption. These factors influence sourcing choices, dictating whether APIs are procured from trusted chemical manufacturers or specialized suppliers with proven compliance histories.

Key Global Suppliers of Testosterone API

1. Bayer AG

Bayer has historically been a prominent supplier of pharmaceutical APIs, including testosterone. Their manufacturing facilities are certified under GMP standards, and their APIs are extensively characterized by high purity levels exceeding 99%. Bayer’s global presence ensures reliable supply chains and adherence to various regulatory jurisdictions, making their testosterone API a preferred choice for many pharmaceutical developers.

2. Cerilliant Corporation

Cerilliant specializes in analytical reference standards and bulk chemical APIs, including testosterone. Their APIs conform to strict regulatory requirements, offering high-quality, analytically characterized material suitable for pharmaceutical application. Their robust quality assurance processes and meticulous lot certification process enhance credibility for API sourcing.

3. Watson Pharma (Part of Teva Pharmaceutical Industries)

Watson Pharma supplies diverse APIs, including testosterone, with GMP certification. Their strategic manufacturing sites in Europe and North America ensure compliance with international standards. Their products are trusted for high purity and consistency, essential for controlled-release systems like Striant.

4. FCT (Falling Chemie-Techniques)

A notable supplier based in Europe, FCT offers testosterone USP/NF grade APIs. Their production facilities are compliant with the latest GMP standards, and they provide customized sizing and formulation attributes aligned with pharmaceutical needs.

5. Imports from India and China

Several API manufacturers in India and China have emerged as cost-efficient sources of testosterone API, supplied by certified facilities with GMP and ISO standards. Companies such as Aurobindo Pharma, Cadila Healthcare, and Zhejiang Jiuzhou Pharmaceutical often provide testosterone APIs at competitive prices. However, due diligence regarding quality certifications and regulatory audits becomes critical when sourcing from these regions.

Criteria for Selecting API Suppliers for Striant

  • Regulatory Compliance: Ensure APIs are manufactured under GMP, with appropriate certifications such as FDA, EMA, or WHO GMP.

  • Quality Specifications: APIs must meet purity (> 99%), potency, and particle size requirements to ensure consistent drug delivery.

  • Traceability and Documentation: Complete batch records and analytical certification facilitate regulatory audits and quality assurance.

  • Supply Chain Reliability: The supplier should demonstrate consistent delivery schedules and backup sources to prevent shortages.

  • Cost and Scalability: Competitive pricing while maintaining quality standards, with capacity for scaled production aligned with market demand.

Industry Trends Affecting Testosterone API Sourcing

a) Increased Regulatory Scrutiny

Global agencies are tightening regulations on hormone APIs, emphasizing testing for contaminants, impurities, and bioequivalence. Suppliers are investing in advanced analytical methods like HPLC and mass spectrometry to meet these compliance standards.

b) Rising Demand Due to Aging Populations

Growing prevalence of hypogonadism and testosterone deficiency in aging males fuels increased demand for testosterone APIs, prompting manufacturers to expand capacity and quality assurance investments.

c) Cost Pressures and Regional Shifts

Manufacturers are exploring cost-effective regions such as India and China without compromising quality. International suppliers are now required to be transparent regarding their GMP compliance and QC processes to gain trust.

d) Vertical Integration and Strategic Partnerships

Pharmaceutical firms are increasingly forming partnerships with specific API manufacturers to secure supply lines and customize API specifications aligned with formulations like Striant.

Challenges in API Sourcing for Striant

  • Regulatory Barriers

Stringent approval processes may delay or complicate API importation, especially from regions with differing standards.

  • Quality Assurance

Variability in API quality can compromise drug performance, emphasizing the need for rigorous testing and supplier audits.

  • Intellectual Property (IP) Considerations

Manufacturers must ensure licensing agreements are properly executed when sourcing from third-party APIs, especially for branded formulations like Striant.

Strategic Recommendations

  • Supplier Qualification Programs

Implement comprehensive assessment protocols, including site audits and testing, to validate supplier capabilities.

  • Long-term Supply Agreements

Establish stable partnerships with trusted API manufacturers to ensure uninterrupted supply and favorable pricing.

  • In-house Quality Control

Invest in accredited analytical laboratories for independent verification of incoming APIs.

  • Monitoring Regulatory Changes

Stay updated on evolving regulations affecting hormone API manufacturing and importation to preempt compliance issues.

Conclusion

The sourcing landscape for testosterone API in the context of Striant underscores the criticality of quality, regulatory adherence, and supply stability. While established players like Bayer and Cerilliant remain prevalent, emerging suppliers in Asia offer cost advantages balanced against the necessity for stringent qualification processes. Strategic sourcing decisions integrating quality assurance, regulatory compliance, and supply reliability are vital for pharmaceutical companies aiming to maintain the integrity and efficacy of Striant.


Key Takeaways

  • High-purity, GMP-compliant testosterone APIs are essential for manufacturing Striant's buccal delivery system.

  • Established global suppliers include Bayer, Cerilliant, and Teva, with regional manufacturers in India and China gaining prominence.

  • Rigorous supplier qualification and comprehensive quality control are vital to mitigate risks related to API variability and regulatory compliance.

  • Industry trends favor increased demand, regulatory tightening, and regional cost advantages, shaping sourcing strategies.

  • Strategic partnerships and supply chain diversification are recommended to ensure consistent API availability and regulatory adherence.


FAQs

1. What are the primary quality requirements for testosterone API used in Striant?
Testosterone API must demonstrate a purity exceeding 99%, compliance with USP or EP standards, consistent particle size for buccal absorption, and be manufactured under GMP conditions with comprehensive documentation.

2. Are regional API manufacturers from Asia suitable for pharmaceutical applications like Striant?
Yes, many Asian manufacturers are GMP-certified and produce pharma-grade testosterone APIs. Due diligence through audits and documentation review is essential before selection.

3. How does API purity impact the efficacy of Striant?
High API purity ensures predictable pharmacokinetic profiles, reduces impurity-related side effects, and guarantees consistent maximum therapeutic benefits.

4. What risks are associated with sourcing testosterone API from emerging regions?
Risks include variability in quality, regulatory discrepancies, supply chain disruptions, and potential challenges in traceability. Proper qualification processes mitigate these risks.

5. How can pharmaceutical firms ensure regulatory compliance when sourcing testosterone API?
Firms should verify supplier GMP certifications, conduct audits, review analytical data, and ensure adherence to pharmacopoeial standards to align with regulatory expectations.


References

[1] U.S. Food and Drug Administration. (2021). Guidance for Industry: Considerations for Combination Product Developers.
[2] European Medicines Agency. (2022). Guideline on quality of testosterone APIs.
[3] Cerilliant Corporation. (2023). API Product Specifications and Certificates of Analysis.
[4] Bayer AG. (2022). Annual Report on API Manufacturing Standards.
[5] Industry Reports on Hormone API Market Trends. (2022).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.